APA (7th ed.) Citation

S, D., S, B., M, S., T, S., K, K., S, L., . . . T, V. (2012). Oncogenic KRAS impairs EGFR antibodies' efficiency by C/EBPβ-dependent suppression of EGFR expression. Neoplasia (New York, N.Y.), 14(3), 190. https://doi.org/10.1593/neo.111636

Chicago Style (17th ed.) Citation

S, Derer, et al. "Oncogenic KRAS Impairs EGFR Antibodies' Efficiency by C/EBPβ-dependent Suppression of EGFR Expression." Neoplasia (New York, N.Y.) 14, no. 3 (2012): 190. https://doi.org/10.1593/neo.111636.

MLA (9th ed.) Citation

S, Derer, et al. "Oncogenic KRAS Impairs EGFR Antibodies' Efficiency by C/EBPβ-dependent Suppression of EGFR Expression." Neoplasia (New York, N.Y.), vol. 14, no. 3, 2012, p. 190, https://doi.org/10.1593/neo.111636.